Lincoln Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)
Lincoln Pharmaceuticals Ltd · Outcome · 29 Oct 2026, 5:51 pm
Lincoln Pharmaceuticals Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 19,135 (+17.1% YoY | +7.9% QoQ) ■ EBITDA: 2,369 (-6.8% YoY | -13.7% QoQ) ■ EBITDA Margin (%): 12.4 (-319 bps YoY | -309 bps QoQ) ■ PAT: 2,043 (+2.2% YoY | -43.6% QoQ) ■ EPS (INR): 10.2 (+2.2% YoY | -43.6% QoQ)
Original exchange filing (PDF)
More announcements from Lincoln Pharmaceuticals Ltd
- Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 29 Oct 2026
- Un-Audited Financial Results For the Quarter and Half year Ended on September 30 ,2026. · 29 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 29 Oct 2026
- LINCOLN PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 29-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 29 Oct 2026
- Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/10/2026 ,inter alia, to consider and approve Standalone and Consolidated .... · 29 Oct 2026
- Change in Senior Management. · 17 Oct 2026
- with reference to the above, Please find enclosed herewith the Minutes of 32nd Annual General Meeting of the Company. · 16 Oct 2026
- Submission of E-Voting Results of 32nd AGM along with the scrutinizer report as per Regulation 44 of SEBI (LODR) Regulation, 2015. · 03 Oct 2026
